[Türkçe]
Turkish Society of Cardiology Cardiooncology Bulletin Year: 3 Number: 2 / 2025


Turkish Society of Cardiology
Cardiooncology

President:
Dr. Elif Eroğlu Büyüköner
Coordinator for the
Board of Directors
Dr. Yusuf Ziya Şener

Members
Dr. Kartal Emre Aslanger
Dr. Fatma Nihan Turhan Çağlar
Dr. Uğur Nadir Karakulak
Dr. Ertuğrul Okuyan
Dr. Evin Bozçalı Polat
Dr. Nafia İnan Kardelen Ohtaroğlu Tokdil
Dr. Omaç Tüfekçioğlu
Dr. Demet Menekşe Gerede Uludağ
 


Turkish Society of Cardiology Young Cardiologists Bulletin / "" Şubat 2025 (2)
Issue Summary
Cardiovascular Comorbidities and Their Prognostic value in Small Cell Lung Cancer Patients with Chemoradiotherapy
Dr. Aytuğ AL

Cardiac Events and Survival in Patients with EGFR-Mutant Non–Small Cell Lung Cancer Treated with Osimertinib
Dr. Aytuğ AL

Cardiotoxicity following Thoracic Radiotherapy for Lung Cancer
Dr. Aytuğ Al

Quantitative Evaluation of Radiation-Induced Heart Disease in Patients with Lung Cancer: A Three-Dimensional Speckle Tracking
Dr. Gamze Gençol Akçay

Immune Checkpoint Inhibitors And Pericardial Disease: A Systematic Review
Dr. Gamze Gençol Akçay

The Cardiac-Related Adverse Events of PD-1/PD-L1 Immunotherapy in Advanced or Metastatic Lung Cancer: A RCT-Based Meta-Analysis
Dr. Gamze Gençol Akçay

Radiation Oncology Opinions and Practice on Cardiotoxicity in Lung Cancer: A Cross-sectional Study by the International Cardio-oncology Society
Rabia Okumuş

CT-Defined Coronary Artery Calcification as a Prognostic Marker for Overall Survival in Lung Cancer: A Systematic Review and Meta-analysis
Rabia Okumuş

Application of Two-Dimensional Speckle-Tracking Echocardiography in Radiotherapy-Related Cardiac Systolic Dysfunction and Analysis of its Risk Factors: A Prospective Cohort Study
Dr. Ayberk Beral

Cardiac Substructure Dose and Survival in Stereotactic Radiotherapy for Lung Cancer: Results of the Multi-Centre SSBROC Trial
Dr. Ayberk Beral
 2025 © Turkish Society of Cardiology.